On December 5, the United Nations’ Economic and Social Council (ECOSOC) hosted its first meeting on the Ebola epidemic’s long-run implications on development in the affected countries.
CGD Policy Blogs
On World AIDS Day in 2003, WHO and UNAIDS launched a campaign called the “3 by 5 initiative,” with the objective to “treat three million people with HIV by 2005.” At that time, AIDS treatment was still prohibitively expensive for poor countries, where only a few thousand people had access to treatment. Thanks to President Bush’s creation of the President's Emergency Plan for AIDS Relief (PEPFAR) program that same year, the number of people on antiretroviral therapy (ART) began to rise dramatically. While the total number of people on ART reached only one million in 2005, the objective to reach three million people was attained in 2007, and the numbers have continued to climb. The numbers have now surpassed 11 million in low- and middle-income countries and 13 million worldwide. (See bottom trend line in figure 1.)
The World Bank on Wednesday released a report titled “The Economic Impact of the 2014 Ebola Epidemic: Short and Medium Term Estimates for West Africa,” which we and other co-authors blogged about yesterday on the World Bank’s site.
This Wonkcast was originally recorded on September 2, 2014.
As the Ebola epidemic continued to spread in West Africa, with more than 3,000 cases and 1,500 deaths, I invited CGD senior fellow Mead Over, a health economist and one of the world’s top experts on the economics of HIV/AIDS, to discuss newly released maps from the World Health Organization (WHO) and measures for limiting the economic fallout from the epidemic.
On September 23, the Washington Post aired a disagreement between the US Center for Disease Control Ebola experts and the Médecins Sans Frontieres Ebola doctors regarding the value of community Ebola treatment centers staffed with community volunteers for Liberia, Guinea, and Sierra Leone.
On September 17, the World Bank issued a preliminary report on the economic impact of Ebola Viral Disease (hereafter Ebola).
It’s too early to know how large the economic impact of Ebola will be on West Africa and the world. Past experience, including the 2002-03 Severe Acute Respiratory Syndrome (SARS) epidemic, suggest it could be very large indeed, especially in the African countries that have been hardest hit. Fortunately, actions that the US and other donor countries take now could help not only to control the epidemic but also to minimize the economic fallout.
As the Ebola outbreak in West Africa persists, some parallels are being drawn between the virus and HIV/AIDS.
CGD and its health team express our condolences to the families of all lost on MH17. We know that many of those attending the International AIDS Conference, which starts this week-end in Melbourne, have been touched personally by the AIDS researchers and activists lost on the plane and will deeply feel their loss.